| INTRODUCTION
Postpartum hemorrhage (PPH) occurs in approximately 5% of all live births and, despite concentrated efforts, remains a leading cause of maternal morbidity and mortality. 1 Because most PPH-related deaths are preventable through the implementation of effective interventions, the recent shift from home births to facility births across lowand middle-income countries (LMIC) raises new opportunities for saving women's lives. 2, 3 Unfortunately, inconsistent and/or delayed use of effective interventions for prevention and treatment of PPH, in addition to other systemic problems in health services (e.g., lack of blood banks, inadequate staffing), has led to continued unacceptable rates of hemorrhage-related maternal deaths. [4] [5] [6] Care bundles have been associated with improved patient outcomes when adherence is high. [7] [8] [9] The concept of care bundles is similar to that of packages and checklists, which have been used by healthcare providers for decades with a similar goal of standardizing and expediting care (Supplementary Box S1). Care bundles may include behaviors, such as the widely used "ABCs" designed to help practitioners remember the sequence for resuscitation, or a number of interventions packaged together, such as the "Active Management of the Third Stage of Labor" (AMTSL) package used to prevent PPH.
In 2001, the Institute for Healthcare Improvement (IHI) developed a formal approach to bundling care to increase the quality and efficiency of care delivery. 10 The IHI defined bundles as "small sets of evidence-based interventions for a defined patient population and care setting that, when implemented together, result in significantly better outcomes than when implemented individually". 10 The "bundles" approach was designed to increase uptake and compliance to recommended interventions. 10 Care bundles differ from other care packages in that compliance is achieved only when all the bundled interventions are completed and recorded. Thus, compliance for the bundle as a whole implies higher rates of compliance for its individual elements. 10 Teamwork, communication, and cooperation are emphasized, because these health systems' processes are required for quality and sustainability. 10 In 2012, WHO published its "Recommendations for the Prevention and Treatment of Postpartum Haemorrhage" to provide evidenceinformed clinical care recommendations for hemorrhage due to uterine atony. 11 However, adherence to these recommendations remains a challenge. 6 The bundle approach has been proposed as a potential PPH recommendations and based on the validated "GRADE Evidence-to-Decision" framework. Twenty-three global maternal-health experts participated in the development process, which was informed by a systematic literature search on bundle definitions, designs, and implementation experiences. Over a 6-month period, the expert panel met online and via teleconferences, culminating in a 2-day in-person meeting.
Results:
The consultation led to the definition of two care bundles for facility implementation. The "first response to PPH bundle" comprises uterotonics, isotonic crystalloids, tranexamic acid, and uterine massage. The "response to refractory PPH bundle" comprises compressive measures (aortic or bimanual uterine compression), the nonpneumatic antishock garment, and intrauterine balloon tamponade (IBT). Advocacy, training, teamwork, communication, and use of best clinical practices were defined as PPH bundle supporting elements.
Conclusion:
For the first response bundle, further research should assess its feasibility, acceptability, and effectiveness; and identify optimal implementation strategies. For the response to refractory bundle, further research should address pending controversies, including the operational definition of refractory PPH and effectiveness of IBT devices. solution to suboptimal adherence to PPH guidelines. 4 Healthcare bundles have been proposed for maternal conditions including placenta previa, elective induction, labor augmentation, vacuum delivery, maternal sepsis, and obstetric anal sphincter injury, 10,12,13 but evidence of their success or failure is lacking. Although many current patient safety programs target PPH, 3, 5, [14] [15] [16] there are no patient care bundles for PPH as defined by the IHI.
K E Y W O R D S
In early 2017, WHO decided to explore whether bundling current WHO-recommended evidenced-based interventions for PPH due to uterine atony might accelerate adoption and adherence to PPH guidelines. The aim of the present study was to describe the first steps toward that goal: the adoption of a bundle definition, the PPH intervention selection criteria, and the process for the development of two PPH care bundles.
| MATERIALS AND METHODS
The consultation for the development of care bundles for PPH was carried out among international maternal health experts between Postpartum hemorrhage was defined as bleeding that a skilled birth attendant (SBA) feels is excessive and worrisome for this exercise. 17 In addition, in the absence of an accepted definition of refractory PPH, it was defined as bleeding that is unresponsive to initial treatment and that triggers an additional set of interventions.
Development of the bundles was undertaken by a panel of experts
with geographic and professional diversity (Supplementary File S1).
The PPH bundles were developed first by conducting a systematic literature search to define care bundles and their essential characteristics in general; and then by identifying criteria to guide the selection of interventions for the PPH bundles. The selection of the interventions to be included in the bundles was made through technical consultations. Figure 1 outlines the process followed for bundle development. guide the selection of interventions, 11 criteria were selected from the validated and WHO-adopted "GRADE Evidence to Decision" framework 18 and one from the care bundle literature 10, 13 (Table 1 ). For settings we considered community settings (i.e., home deliveries, health after delivery, and dispensary deliveries) assisted by SBAs, primary healthcare (PHC) centers, and hospitals. All WHO recommendations were assessed for appropriateness within each of these settings, resulting in 13 interventions eligible for inclusion ( Table 2 ). The 13 interventions were then classified according to purpose (prevention, first response, and response to refractory PPH); setting (as above); application to vaginal delivery, cesarean delivery, or any type of delivery; and application during the third stage of labor or the first 24 hours postpartum. From a total of 38 possible combinations of the 13 interventions that emerged from the above classification, those that included three or more interventions, were judged to be applicable in most settings, were intended for use by skilled birth attendants, and would be applicable to most women with PPH due to uterine atony were selected. Two recommended interventions, hemostatic surgery and arterial embolization, were excluded from the bundles because neither is feasible in most settings nor applicable to most women with PPH due to uterine atony.
The definition of care bundles, the criteria for selecting interventions, and the potential PPH care bundles were agreed upon by the experts through iterative consensus exercises. The process used a three-stage modified Delphi method, 19 The experts met for an in-person consultation December 7-8, 2017, to consolidate agreements and to address disagreements.
Presentations and discussions were held in plenary sessions, where the "poll everywhere" audience response system and paper ballots were used to record individual decisions anonymously. See Supplementary File S5 for details.
| RESULTS
In the literature search, 730 articles met the initial criteria, of which 415 were excluded after reviews of the abstract and full text ( Supplementary Fig. S1 ). What is the certainty of the evidence for the costs of the intervention? If resource use is considered critical for a recommendation, the less certain the evidence for resource requirements, the less likely it is that a panel should select or not the intervention 6 (4-7.5) No
7
Cost-effectiveness Judgments about the cost effectiveness of an intervention need to take into account several criteria including the balance between the desirable and undesirable effects (the net benefit); the certainty of the evidence of effects and uncertainty about or variability in how much individuals value the main outcomes; and resource requirements (cost) and uncertainty about the costs 7.5 (7-8) Yes
8
Resources required How large are the resource requirements (costs in terms of both money and time) of the bundle? The greater the cost, the less likely it is that a bundle will be selected 8 (7.5-9) Yes 9 Equity What would be the impact of the bundle on health equity? This criterion evaluates if a bundle is expected to reduce health inequities. It considers whether a bundle will reduce differences in the effectiveness for disadvantaged populations within countries, such as low-income groups, less educated individuals, and/or rural populations 8 (6.5-9) Yes 10 Acceptability Is the bundle acceptable to key stakeholders (women and providers)? A bundle might vary on its acceptability level due to ethical principles (e.g., autonomy, beneficence or justice), as well as the distribution of the desirable and undesirable effects and costs (who benefits or is harmed, and who pays or saves) 8 (6.5-9) Yes Tables S1 and S2 ). Three PPH care bundles that met the agreed criteria were initially identified: (1) prevention and recognition of PPH;
(2) first response to PPH; and (3) response to refractory PPH. Among these three bundles, one was rejected and two were accepted.
| Prevention and recognition of PPH bundle
The bundle of interventions proposed for PPH prevention included uterotonics, controlled cord traction (CCT), and uterine tone assessment. In the online rounds, this bundle received high relevance rates and strong agreement overall ( Supplementary Table S3 ). However, several issues emerged during the online rounds and were discussed at the in-person meeting. 
| First response to PPH bundle

| Response to refractory PPH bundle
The indicator measurability, and no or minimal resources required), and there was no consensus for the equity criteria ( Supplementary Table S3 ).
During the discussions at the in-person meeting, the following issues were discussed for the refractory bleeding bundle. First, uterotonics, crystalloids, and TXA were already included in the first response bundle, and therefore did not need to be listed as bundle components.
Second, IBT is currently recommended by the WHO, but is considered controversial by some members owing to recently published evidence. [22] [23] [24] [25] Third, in cases where IBT or NASG is not available, or for use during the period before IBT and NASG are applied, bimanual uterine compression and external aortic compression were suggested for bundle inclusion by some experts. Fourth, concerns were raised that implementing all elements of the bundle might result in the overtreatment of women with refractory hemorrhage whose condition was not worsening. Last, an area of contention was whether or not the "response to refractory PPH bundle" should be a bundle. Some members mentioned that the conditional, variable, and progressive changes of refractory hemorrhage may make this condition less appropriate for the bundle approach.
In response to these concerns, the panel considered the follow- The primary rationale for keeping these interventions in a bundle was, first, that the "care package" approach has been recommended by WHO since 2012; and second, the rationale for proposing a bundle approach was to improve strategies for compliance with best practices.
The original aim was that the PPH bundles would apply to both vaginal and cesarean delivery; however, additional discussions made it clear that post-cesarean bleeding might require a modified approach for the following reasons: uterine massage may not be effective for these women; uterotonics and IV fluids are likely to be already in place, making these two components of the first response bundle redundant for most patients; and the early detection of PPH is likely to use different strategies as compared with vaginal delivery. Therefore, the opinion of the group was that a modified bundle that addresses the unique circumstances and 
Response to refractory PPH bundle
Compressive measure (aortic compression or bimanual uterine compression)
Intrauterine balloon tamponade
Non-pneumatic anti shock garment Notes: A continuing dose of uterotonics (e.g., oxytocin diluted in isotonic crystalloids) and a second dose of tranexamic acid should be administered during the application of this bundle.
bundles" and will be re-examined as new evidence emerges during the process of updating WHO recommendations and guidelines. 26 
| DISCUSSION
In the present consultation, a systematic approach was used to review By contrast, the issues raised about the response to refractory PPH may merit further analyses and discussions. Although several publications have reported positive outcomes with IBTs, 23-25 a randomized controlled trial reported safety concerns associated with implementation of a condom catheter IBT. 22 Similarly, preliminary results of a stepped-wedge cluster randomized trial in Egypt, Senegal, and Uganda raised safety con- For the response to refractory PPH bundle, it is a priority to solve pending controversies including the operational definition of refractory PPH, and to better understand the effectiveness of various IBT devices. For any PPH bundle, strengthening commodity supply chains and encouraging behavior change are critical to implementation. Assessment of facilitators and barriers should guide the development of the strategy. The approach will need to be tailored to local contexts to ensure sustainability. Similarly, leadership from ministries and key stakeholders will be critical for successful bundle implementation. We expect that the PPH bundles will reduce rates of severe PPH, morbidity, and mortality, through improved quality of care and adherence to global, high-quality guidelines; however, this has not yet been demonstrated. Future research must rigorously assess how these bundles are implemented in practice, including the mechanisms of impact and how these are influenced by the context. 28 Given these considerations, there will be a need for implementation research to determine if the bundling approach will ultimately make a difference in saving women's lives from PPH. 
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